Enlightenment Research’s Chemours CC Stock Holding History

Enlightenment Research’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,900	Closed	-$212K	–	120
2019 Q2	$212K	Buy	+5,900	New	+$174K	0.11%	240

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Enlightenment Research's CC Position: Q3 2019 in Review

Enlightenment Research sold out of Chemours (CC) in Q3 2019, closing a stake of 5,900 shares — an estimated $212K sold.

Enlightenment Research first reported a position in CC in Q2 2019 and held it in 1 quarter. The position peaked at $212K in Q2 2019. 418 funds tracked by Wall St. Rank hold CC as of Q3 2019.

Enlightenment Research reported no remaining Chemours position as of Q3 2019 after selling out during the quarter.
Enlightenment Research sold 5,900 Chemours shares in Q3 2019, an estimated $212K.
Enlightenment Research first reported a position in Chemours in Q2 2019 and held it in 1 quarter.
Enlightenment Research's Chemours position peaked at $212K in Q2 2019.
418 funds tracked by Wall St. Rank held Chemours as of Q3 2019.

Based on Enlightenment Research's 13F filing for Q3 2019, filed 16 Oct 2019.